Unknown

Dataset Information

0

Tranexamic Acid Attenuates the Progression of Posttraumatic Osteoarthritis in Mice.


ABSTRACT:

Background

Posttraumatic osteoarthritis (OA) is a common disorder associated with a high socioeconomic burden, particularly in young, physically active, and working patients. Tranexamic acid (TXA) is commonly used in orthopaedic trauma surgery as an antifibrinolytic agent to control excessive bleeding. Previous studies have reported that TXA modulates inflammation and bone cell function, both of which are dysregulated during posttraumatic OA disease progression.

Purpose

To evaluate the therapeutic effects of systemic and topical TXA treatment on the progression of posttraumatic OA in the knee of mice.

Study design

Controlled laboratory study.

Methods

OA was induced via anterior cruciate ligament (ACL) transection on the right knee of female mice. Mice were treated with TXA or vehicle intraperitoneally daily or intra-articularly weekly for 4 weeks, starting on the day of surgery. Articular cartilage degeneration, synovitis, bone erosion, and osteophyte formation were scored histologically. Micro-computed tomography evaluation was conducted to measure the subchondral bone microstructure and osteophyte volume. Cartilage thickness and bone remodeling were assessed histomorphometrically.

Results

Both systemic and topical TXA treatment significantly reduced cartilage degeneration, synovitis, and bone erosion scores and increased the ratio of hyaline to calcified cartilage thickness in posttraumatic OA. Systemic TXA reversed ACL transection-induced subchondral bone loss and osteophyte formation, whereas topical treatment had no effect. Systemic TXA decreased the number and surface area of osteoclasts, whereas those of osteoblasts were not affected. No effect of topical TXA on osteoblast or osteoclast parameters was observed.

Conclusion

Both systemic and topical TXA exerted protective effects on the progression of posttraumatic OA. Drug repurposing of TXA may, therefore, be useful for the prevention or treatment of posttraumatic OA, particularly after ACL surgery.

Clinical relevance

TXA might be beneficial in patients with posttraumatic OA of the knee.

SUBMITTER: Xie W 

PROVIDER: S-EPMC10905980 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tranexamic Acid Attenuates the Progression of Posttraumatic Osteoarthritis in Mice.

Xie Weixin W   Jiang Shan S   Donat Antonia A   Knapstein Paul Richard PR   Albertsen Lilly-Charlotte LC   Kokot Judith Luisa JL   Erdmann Cordula C   Rolvien Tim T   Frosch Karl-Heinz KH   Baranowsky Anke A   Keller Johannes J  

The American journal of sports medicine 20240202 3


<h4>Background</h4>Posttraumatic osteoarthritis (OA) is a common disorder associated with a high socioeconomic burden, particularly in young, physically active, and working patients. Tranexamic acid (TXA) is commonly used in orthopaedic trauma surgery as an antifibrinolytic agent to control excessive bleeding. Previous studies have reported that TXA modulates inflammation and bone cell function, both of which are dysregulated during posttraumatic OA disease progression.<h4>Purpose</h4>To evaluat  ...[more]

Similar Datasets

| S-EPMC11885341 | biostudies-literature
| S-EPMC6814162 | biostudies-literature
2022-11-29 | GSE206513 | GEO
| S-EPMC9741608 | biostudies-literature
| S-EPMC6138726 | biostudies-literature
| S-EPMC3992997 | biostudies-literature
| S-EPMC6393186 | biostudies-literature
| S-EPMC8804845 | biostudies-literature
| PRJNA851254 | ENA
| S-EPMC9945017 | biostudies-literature